Imperial College London, Chair of Respiratory Medicine (Clinical)

Chair of Respiratory Medicine (Clinical)

National Heart and Lung Institute, Faculty of Medicine

Salary: £82,096 to £110,683 per annum, dependent on level of seniority plus £2,162 London Allowance per annum

Imperial College London is consistently rated amongst the world’s best universities, renowned for its ground-breaking research, talented community of staff, students, and alumni, and its international reach.

We wish to appoint a world-leading clinical scientist to a Chair of Respiratory Medicine, within our National Heart and Lung Institute, Faculty of Medicine whose focus will be to advance our ongoing research programme in experimental medicine in airways diseases. This will align with NHLI’s Strategic Research Plan (2019 – 2024) and the College’s desire to consolidate its respiratory science into a newly refurbished building located alongside our existing Cardiology and Vascular Laboratories on the Hammersmith and White City Campuses.

The College is in an outstanding position to combine exceptional clinical expertise with innovative science to drive forward precision medicine in airways diseases. Current Imperial College NHLI’s research programmes range from population health and epidemiology, early-life cohorts of chronic obstructive pulmonary disease (COPD), occupational asthma, to translational expertise in severe asthma investigating molecular mechanisms with multi-omics analyses and encompass both paediatric and adult chronic airways disease.

In this post, you will lead and establish clinical links and strengthen and integrate research within the severe asthma and COPD service of the Imperial AHSC (Academic Health Science Centre), build up an experimental/translational medicine programme including patients with chronic airways diseases, develop strong collaborative and interdisciplinary links with the National Phenome Centre to advance research in systems medicine, and Faculty of Engineering to advance AI (Artificial Intelligence) with imaging and biomarkers for precision medicine. In addition, you will also be expected to lead on the development of a Strategic Centre for Precision Medicine in Airways disease, spanning experimental medicine (including airway challenge studies), biomarker discovery, AI/Data Sciences, and systems medicine.

In order to be successful in this role, you must hold a MD, PhD, or equivalent in a related field. In addition, you must also have an international reputation in your field, established track record of research, and evidence of excellent leadership skills. You must have the appropriate UK Clinical Specialist Registration with licence to practise, or must be eligible for registration within six months of interview and will need to fulfil the requisite clinical checks.

A full list of responsibilities and essential requirements can be seen in the attached Job description.

For further information about the college and benefit available to staff, please see the Further Particulars on our website.

As this post is exempt from the Rehabilitation of Offenders Act 1974, a satisfactory Disclosure and Barring Service (DBS) check, at the appropriate level, will be required.

For informal enquiries, please contact, Professor Edwin Chilvers, Head of NHLI, e-mail: e.chilvers@imperial.ac.uk  or Professor Sebastian Johnston, Head of Airways Disease Section, e-mail: s.johnston@imperial.ac.uk or Professor Sejal Saglani, Head of Inflammation, Repair & Development Section, e-mail: s.saglani@imperial.ac.uk. These enquiries will be handled in strict confidence.

For further information on the recruitment process please contact: Maria Monteiro, Senior Appointments Manager, e-mail: m.monteiro@imperial.ac.uk Telephone: +44 (0)207 594 5498

Closing Date: 26 July 2021 (Midnight BST)

We are committed to equality of opportunity, to eliminating discrimination, and to creating an inclusive working environment for all. We therefore encourage candidates to apply irrespective of age, disability, marriage or civil partnership status, pregnancy or maternity, race, religion and belief, gender identity, sex, or sexual orientation. We are an Athena SWAN Silver Award winner, a Disability Confident Leader and a Stonewall Diversity Champion.

NHLI is an Athena SWAN Bronze Award holder and a Stonewall Diversity Champion.

The College is a proud signatory to the San-Francisco Declaration on Research Assessment (DORA), which means that in hiring and promotion decisions, we evaluate applicants on the quality of their work, not the journal impact factor where it is published. For more information, see: www.imperial.ac.uk/research-and-innovation/about-imperial-research/research-evaluation/

The College believes that the use of animals in research is vital to improve human and animal health and welfare. Animals may only be used in research programmes where their use is shown to be necessary for developing new treatments and making medical advances. Imperial is committed to ensuring that, in cases where this research is deemed essential, all animals in the College’s care are treated with full respect, and that all staff involved with this work show due consideration at every level www.imperial.ac.uk/research-and-innovation/about-imperial-research/research-integrity/animal-research